Compare ALLO & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | MYFW |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 220.8M |
| IPO Year | 2018 | 2018 |
| Metric | ALLO | MYFW |
|---|---|---|
| Price | $1.50 | $25.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | $8.67 | ★ $24.25 |
| AVG Volume (30 Days) | ★ 2.4M | 26.6K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 391.62 |
| EPS | N/A | ★ 1.28 |
| Revenue | N/A | ★ $95,514,000.00 |
| Revenue This Year | N/A | $15.96 |
| Revenue Next Year | $100.00 | $13.77 |
| P/E Ratio | ★ N/A | $19.42 |
| Revenue Growth | N/A | ★ 19.92 |
| 52 Week Low | $0.86 | $17.10 |
| 52 Week High | $3.78 | $25.84 |
| Indicator | ALLO | MYFW |
|---|---|---|
| Relative Strength Index (RSI) | 61.26 | 73.66 |
| Support Level | $1.39 | $23.72 |
| Resistance Level | $1.52 | $24.75 |
| Average True Range (ATR) | 0.10 | 0.59 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 87.50 | 98.47 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.